Preparation and properties of branched oligoglycerol modifiers for stabilization of liposomes.
Ishihara
Atsushi
A
Drug Formulation Research and Development Laboratories, Production Division, Kyowa Hakko Kirin Co, Ltd, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8731, Japan.
Yamauchi
Masahiro
M
Kusano
Hiroko
H
Mimura
Yukiteru
Y
Nakakura
Masashi
M
Kamiya
Masaaki
M
Katagiri
Ayato
A
Kawano
Masaki
M
Nemoto
Hisao
H
Suzawa
Toshiyuki
T
Yamasaki
Motoo
M
D000327:Adsorption / Q000187:drug effects; D000818:Animals; D001798:Blood Proteins / Q000493:pharmacokinetics*; D002626:Chemistry, Pharmaceutical / Q000379:methods; D004317:Doxorubicin / Q000493:pharmacokinetics; D004339:Drug Compounding / Q000379:methods*; D004355:Drug Stability; D005990:Glycerol / Q000031:analogs & derivatives* / Q000737:chemistry; D007275:Injections, Intravenous; D008081:Liposomes / Q000008:administration & dosage* / Q000097:blood / Q000138:chemical synthesis / Q000737:chemistry; D008297:Male; D010714:Phosphatidylethanolamines / Q000737:chemistry; D010743:Phospholipids / Q000138:chemical synthesis; D051381:Rats; D011919:Rats, Inbred Strains; D019809:Streptavidin / Q000737:chemistry; D013499:Surface Properties
D001798:Blood Proteins; D008081:Liposomes; D010714:Phosphatidylethanolamines; D010743:Phospholipids; C038089:1,2-distearoylphosphatidylethanolamine; D004317:Doxorubicin; D019809:Streptavidin; D005990:Glycerol